BeStock  
Stocks › Biotechnology › XENE

Xenon Pharmaceuticals XENE

US equityMarket cap rank #2284Biotechnology
$37.04 −$0.52 (-1.38%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $37.04 0.00%
Open$37.22
Prev close$37.56
Day range$36.81 – $37.97
Volume1.09M
Market cap$3.64B
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-8.6x
CheapRich

Near the top of its 5-year range · 97th percentile, 5-year average -14.8x

Price / book3.5x
CheapRich

Below its usual level · 37th percentile, 5-year average 4.1x

#3943 of 5330 stocks by PB (1 = cheapest)

Price / sales530.5x
CheapRich

Around its usual level · 49th percentile, 5-year average 8,163.8x

#5064 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-24x-18x-12x-6xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$58.10
Price vs. fair value-36.2%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 3.47 – 4.13 37% (cheaper than usual) #3943 of 5330 (1 = cheapest)
PE -8.63 -8.24 -14.82 97% (pricier than usual) –
PS 530.48 1,060.95 8,163.82 49% (cheaper than usual) #5064 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on XENE.

Sign in to join the discussion.

Scroll to Top